AQP4 and myeloid sarcoma: Immune features and the cytokine profile in the cerebrospinal fluid (CSF) significantly vary in patients with MS, AQP4-positive NMOSD, and MOGAD, suggesting that these are different autoimmune demyelinating diseases [78,79].